To validate whether Melk acts as a downstream effector of UBAP2L in regulating ccRCC sunitinib resistance, we performed rescue assays by overexpressing Melk in UBAP2L knockdown 786-O and Caki-1 cells. Here, MELK is linked to nonpapillary renal cell carcinoma.